IP Library Granted Patent US 9,259,685
Granted Patent B2
US 9,259,685 · App. 14/603,524 · Granted Feb 16, 2016

Curable compositions and membranes

Inventors: Harro Antheunis (Tilburg, NL); Jacko Hessing (Tilburg, NL); Bastiaan Van Berchum (Tilburg, NL)
Assignee: Fujifilm Manufacturing Europe BV
B01D61/422B01D61/44B01D67/0006B01J39/20B01J47/12C02F1/441C02F1/4691C02F1/4693C02F1/4695C08F220/60C08J5/2243H01M8/103H01M8/1027H01M8/1044H01M8/1048H01M8/1058H01M8/1067H01M8/1072B01D2323/30B01D2323/34B01D2323/345C08J2333/26H01M2300/0082H01M2300/0091Y02E60/521
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,259,685
App. No.
14/603,524
Granted
Feb 16, 2016
Kind
B2
Abstract

A curable composition comprising: (i) 2.5 to 50 wt % crosslinker comprising at least two acrylamide groups; (ii) 12 to 65 wt % curable ionic compound comprising an ethylenically unsaturated group and a cationic group; (iii) 10 to 70 wt % solvent; and (iv) 0 to 10 wt % of free radical initiator; and (v) non-curable salt; wherein the molar ratio of (i):(ii) is >0.10. The compositions are useful for preparing ion exchange membranes.

Claims (28)

1. A membrane obtained from a process comprising the following steps:

applying a curable composition to a support; and

curing the composition to form a membrane;

wherein the curable composition comprises:

(i) 2.5 to 50 wt % crosslinker comprising at least two acrylamide groups;

(ii) 12 to 65 wt % curable ionic compound comprising an ethylenically unsaturated group and a cationic group;

(iii) 10 to 70 wt % solvent;

(iv) 0 to 10 wt % of free radical initiator; and

(v) non-curable salt comprising a cation and an anion, wherein the anion is not sulfate;

wherein the molar ratio of (i):(ii) is greater than and less than 5 0.10.

2. The membrane according to claim 1 wherein the total wt % of components (i) and (ii) relative to the total weight of the composition is 30 to 88 wt %.

3. The membrane according to claim 1 comprising 2 to 50 wt % of non-curable salt as component (v).

4. The membrane according to claim 1 wherein the molar ratio of (i):(ii) is at least 0.15 and which comprises 20 to 65 wt % of component (ii).

5. The membrane according to claim 1 wherein the solvent comprises water and a water-miscible organic solvent.

6. The membrane according to claim 1 which comprises 0.005 to 10 wt % photoinitiator as component (iv).

7. The membrane according to claim 1 which is free from ethylenically unsaturated compounds other than components (i) and (ii).

8. The membrane according to claim 1 wherein the ethylenically unsaturated group is an acrylamide or a methacrylamide group.

9. The membrane according to claim 1 wherein the composition comprises:

(i) 5 to 35 wt % crosslinker comprising at least two acrylamide groups;

(ii) 20 to 65 wt % curable ionic compound comprising an ethylenically unsaturated group and a cationic group; and

(iii) 16 to 45 wt % solvent;

(iv) 0.01 to 2 wt % of photoinitiator; and

(v) 3 to 40 wt % of non-curable salt comprising a cation and an anion, wherein the anion is not sulfate;

wherein the molar ratio of (i):(ii) is at least 0.15.

10. The membrane according to claim 1 wherein the molar ratio of (i):(ii) is at least 0.15 and less than 1.5.

11. The membrane according to claim 1 wherein the composition is cured by irradiation with an electron beam or UV light for a period of less than 30 seconds.

12. The membrane according to claim 1 wherein the curable composition is applied continuously to a moving support using a manufacturing unit comprising a curable composition application station, an irradiation source for curing the composition, and a membrane collecting station and wherein the support moves from the curable composition application station to the irradiation source and to the membrane collecting station.

13. The membrane according to claim 9 wherein the molar ratio of (i):(ii) is less than 1.5.

Priority Claims (1)
GB 0921951.0 · Dec 16, 2009 · national
Continuity (2)
Division 13516429
Related Publication 20150129428A1 · May 14, 2015